Introduction
Type 1 diabetes (T1D) is an autoimmune disease affecting millions of people worldwide, wherein the immune system destroys the insulin producing β cells within the Islets of Langerhans [1] . While transplantation of donor islets has been demonstrated as a viable therapy by the Edmonton protocol (REF), donor islets are scarce and a high number is required to overcome hypoxia-induced cell death [2] . Alternately, β cells can be derived from human pluripotent stem cells (hPSCs), which have the capacity to self-renew and differentiate, making them attractive for regenerative medicine and cell therapy applications. A significant amount of work has focused on deriving β -like cells from pluripotent stem cells, including work done in our own lab [3] [4] [5] [6] . Recently, the Melton group and the Kieffer group have reported a significant breakthrough in generating glucose responsive insulin producing β cells from hPSCs in vitro [3, 7] . While this will overcome the cell source restriction, the next step towards successful clinical translation of hPSC derived β cells for T1D therapy will require protection of the cells from the host immune system [8] .
A well-studied approach to immunoisolate implanted primary islets for T1D treatment is to encapsulate the donor islets within a material which acts as a semipermeable membrane. This allows for the diffusion of nutrients and waste, but isolates and protects the cells from the larger immune cells [9] [10] [11] [12] . Alginate is well-suited for this purpose because cells can be encapsulated with high viability, while having excellent biocompatibility and providing immunoisolation of the encapsulated cells. Recently, Omid et al. have shown that barium alginate capulesHence it will be relevant to evaluate if alginate capsules can also be used to deliver hPSC-derived islet-like cells. Due to its excellent biocompatibility, alginate has already been tested for encapsulation and differentiation of mouse [13] [14] [15] [16] and human [17] [18] [19] [20] [21] [22] pluripotent stem cells (m/h-PSCs). In our recent work, we have reported successful derivation of insulin producing β-cells from hPSCs encapsulated in calcium alginate capsules, towards a directly transplantable T1D treatment option [23] . Interestingly, we even observed significant enhancement in pancreatic maturation of hPSCs when differentiated under encapsulation, which renders calcium alginate capsules as an attractive platform for differentiation, in addition to immune protection.
While calcium alginate has been extensively used in hPSC literature, it is limited in its in-vivo applications because calcium ions can be easily displaced by monovalent cations, such as sodium, resulting in weakening of the capsules over time [24, 25] . Alginate is composed of mannuronic (M) and guluronic (G) acid, which forms a 3D network when divalent cations bind with the G residues of two adjacent polymer chains [26] . While calcium is commonly used for cell encapsulation, other divalent cations such strontium and barium can also be used. In comparison to calcium, barium binds to alginate with a much higher affinity, resulting in more robust capsules [27, 28] . Thus barium alginate (BAlg) capsules have been extensively used for encapsulation of islets for T1D treatment [29] [30] [31] [32] [33] . However, BAlg has been less explored for pluripotent stem cell encapsulation, with few reported studies in adult stem cells [34] [35] [36] [37] The only successful study with hESCs is by Dean et al. , who showed that hESCs encapsulated in BAlg could survive and differentiate when transplanted in mice for a period of four weeks [38] .
Thus, the favorable mechanical properties of BAlg capsules warrant investigation of its potential for hESC encapsulation and differentiation.
The effect of insoluble physical cues, such as substrate stiffness or extracellular matrix (ECM) molecules, on stem cell differentiation is well-established [39] [40] [41] [42] . In the context of endoderm specific differentiation, our group has demonstrated the feasibility of driving early germ layer differentiation of mESCs by modifying the properties alginate and fibrin substrates, in the absence of chemical inducers [43] [44] [45] [46] . Hence even though pancreatic differentiation of encapsulated hESCs will be directed by chemical cues, it is likely that capsule properties will affect the fate of encapsulated cells. Information is largely lacking in the context of pancreatic differentiation, and is the primary objective of this study. The physical properties of alginate capsules can be modulated by changing the alginate (M/G ratio) and/or cation (Ca, Ba, Sr) type and concentration [28, 47] . As a general rule of thumb, increasing cation concentration will increase the stiffness of the resulting capsule by higher crosslinking of G residues; these effects are further enhanced by cations such as barium which have higher binding affinity [28, 48] . All of these can affect the fate and response of encapsulated cells [49] [50] [51] . Hence, while engineering an encapsulation system for hPSCs, it is necessary to evaluate the effect of substrate properties on the fate of encapsulated cells.
The objective of this study was to investigate, for the first time, the use of BAlg encapsulation for pancreatic differentiation of hESCs, and determine how BAlg properties influence growth and subsequent differentiation of encapsulated hESCs. Overall it was observed that the efficiency of chemical induction was largely dependent on the properties of encapsulating substrate, even though diffusion was never restrictive within the capsules. Cell growth was observed to be favorable under the low stiffness regime, and was highly suppressed under high stiffness conditions. Interestingly, the effect of differentiation was more complex and differed based on stage of differentiation, possibly due to the complexity of the interaction of physical cues with non-linear signaling pathways. Increased alginate capsule stiffness appeared to promote TGFβ signaling during the definitive endoderm (DE) stage, which enhanced DE differentiation.
However, increased substrate stiffness also promoted sonic hedgehog signaling at the pancreatic progenitor (PP) stage, which suppressed PP differentiation. Overall, cell growth and hESC-PP differentiation was found to be favorable in the stiffness range of approximately 4-7 kPa. 
Materials and Methods

Barium alginate encapsulation of hESCs
A single cell suspension of UD hESCs was encapsulated by modifying our previous encapsulation protocol with the use of BaCl 2 [23] (details in SI methods). hESCs were encapsulated using 10, 15, 20, 50 or 100 mM BaCl 2 . Alginate capsules were incubated for 6-8 min in the BaCl 2 solution. Capsules were washed three times with DMEM/F12 and suspended in mTeSR1 with 10 µM Y-27632 for 4 day, followed by 2 days in mTeSR1 alone to allow for colony formation, prior to differentiation.
Barium alginate capsule characterization
Alginate disks were formed using a 1.7 cm diameter mold, and crosslinked with 10, 15, 20, 50, and 100 mM BaCl 2 . AFM force indentation measurements were performed using the MFP-3D Atomic Force Microscope (Asylum Research, CA, USA). The hydrogels were maintained in saline after formation to ensure their hydrated state. The stiffness of each alginate gel was measured at n = 3 random locations and approximately 16 force curves were taken over a 4x4 grid at each location on each sample. Diffusivity was examined by first forming alginate capsules using 10, 20, and 100 mM BaCl 2 without cells. 1 ml of alginate was used to form capsules for each BaCl 2 concentrations, and was loaded with 2 mg of bovine serum albumin (BSA, (Sigma-Aldrich)). The capsules were suspended in 2 ml of 0.9% saline, and the supernatant was sampled for released BSA over 24 hours. BSA was measured using the BCA total protein assay (Thermo Scientific) according to manufacturer's instruction, and analyzed using a Synergy 2 multi-mode Microplate Reader (BioTek, Winooski, VT, USA).
Differentiation of encapsulated hESCs
The stage-wise induction protocol for the pancreatic differentiation of hESCs was identical to our previous study, ending at the pancreatic progenitor stage instead of the maturation stage [4] . 
Image analysis
The stock LIVE images from LIVE/DEAD analysis were processed using Metamorph. Briefly, the processing steps included thresholding to eliminate background, after which the image was binarized to create a black and white mask; filtered to detect the edges of the individual colonies, forming a mask or outline. From the mask, using Integrated Morphometry Analysis, data was generated for each colony within each image, measuring the area of the colony. This image processing was done on images taken on 5 capsules, each day for each condition. 
hESC proliferation and death
Cell proliferation was measured using AlamarBlue (Life Technologies) assay according to manufacturer's instructions. Cell death was measured by analysis of released lactate dehydrogenase (LDH), using the CytoTox 96® Non-Radioactive Cytotoxicity assay according to manufactures instruction. Assay details are found in the SI methods.
qRT-PCR for gene expression analysis
Cells were decapsulated with 100 mM EDTA (Sigma) and washed twice with PBS before lysis. mRNA was isolated using the NucleoSpin RNA II kit (Macherey-Nagel, Bethlehem, PA). cDNA was obtained using ImpromII Reverse Transcription (Promega, Madison, WI). Each PCR reaction contained 5 µl SYBR Green Master Mix (Agilent, Santa Clara, CA), 2 µl nuclease free H 2 O, 2 µl primer, and 1µl cDNA. Samples were normalized to the house keeping gene GAPDH and analyzed relative to UD hESCs using the ∆∆Ct method. Gene expression was measured with quantitative polymerase chain reaction (qRT-PCR) using an MX3005P system (Agilent).
MagPix for TGFβ pathway signaling analysis
The TGFβ pathway was analyzed using the MILLIPLEX MAP TGFβ Signaling Pathway Magnetic Bead 6-Plex (Millipore) for pSMAD2, pSMAD3, pERK1/2, and pAKT as well as total TGFβII and SMAD4 according to manufactures instruction (details in SI methods). Fluorescence intensity was measured using the xMAP (Luminex, Austin, TX) machine. The total protein was measured using a BCA total protein kit, according to manufactures instruction.
Immunostaining
Encapsulated cells were fixed with 4% formaldehyde for 20 min and cryopreserved with 30% sucrose for 24 hours before embedding in OCT for cryo-sectioning. H&E staining was done to determine the gross morphology of the colonies for each encapsulation condition. For immunostaining, blocking was done with 10% donkey serum in PBS for 1 hour. Primary antibody staining was done overnight at 4°C, followed by addition of the secondary antibody for 45 minutes at room temperature. Finally, slides were covered with hardening mounting medium containing DAPI (Vectashield, Vector laboratory). Slides were washed three times with PBS in between each step of the staining protocol. Primary and secondary antibodies and dilution details are located in the SI methods.
Statistical analysis
Data were presented as mean ± SD. Statistical significance between two groups was determined using the two tailed Student T-test for two group comparisons. Statistical significance comparing multiple groups was determined using one-way ANOVA, with Tukeys or Games-Howell post hoc testing for homogeneous or inhomogeneous variance, respectively. Probability values at P < 0.05(*) and P < 0.01 (**) indicated statistical significance.
Results
Barium alginate stiffness, and not diffusion, affects encapsulated hESCs
The mechanical properties, namely stiffness, of organs can vary in a wide range: 1 -10 kPa in soft tissue like brain or muscle, while hard tissue such as collagenous bone is on the order of 100 kPa [42] . Hence we first identified the range of cation concentrations which produces capsules in the range of 1 -100 kPa, by varying barium concentrations (5 -200 mM BaCl2).
Alginate capsules were formed by drop-wise addition of alginate into the cation solution, resulting in capsules of 2.07±0.1 mm in diameter. Barium alginate capsules of this size have recently been shown to strongly resist fibrosis compared to traditionally used capsules of smaller diameter for up 175 days in immune competent mice, while supporting islet function and viability [32] . Resulting capsule stiffness was measured using atomic force microscopy (AFM) micro-indentation to determine the Young's Modulus. Capsules created with less than 10 mM BaCl 2 did not form homogenous capsules (data not shown), while those created with greater than 100 mM BaCl 2 were outside the desired stiffness range noted above. The Young's modulus of the BAlg capsules progressively increased from 3.9±1.3 kPA in the lowest BaCl 2 concentration (10 mM), to 73.3±22.4 kPA in the highest BaCl 2 concentration (100 mM, Figure   1A ).
The chosen range of capsule stiffness was next explored for encapsulating undifferentiated (UD) hESCs. Cells were suspended in 1.1% alginate with 0.2% gelatin and added to a solution of the desired BaCl 2 concentration for crosslinking (Schematic in Figure 1B ). After 6 days of propagation, colony formation was minimal in the 50 and 100 mM BAlg capsules, as compared to cells encapsulated in 10 -20 mM BAlg capsules (colonies indicated with white arrows, Figure   1C ). Since the density of crosslinking could also possibly modulate the diffusivity of the capsule to nutrients, growth factors, or small molecules in the media, we measured BSA diffusivity with changing alginate crosslinking. BSA was chosen for this study for its high molecular weight of 66.5 kDA, in comparison to key differentiation inducers: ActivinA (26 kDA), Wnt3A (40 kDA), CYC (0.4 kDA), and Retinoic Acid (0.3 kDA). Figure 1D shows that there was insignificant difference in the release profiles of the BSA loaded BAlg capsules of different crosslinking densities after 24 hours. This indicates that for the range of BAlg used in this study, the encapsulated cells are unlikely to experience any difference in media exposure from diffusion limitations. On the other hand, the effect of crosslinking on the resultant capsule stiffness was significant.
Capsule stiffness suppresses the growth dynamics of encapsulated hESCs
We next quantified the effect of varying BaCl 2 concentration, and thereby BAlg capsule stiffness, on the viability and proliferation of encapsulated hESCs throughout differentiation. UD hESCs were encapsulated using 10, 15, 20, 50, and 100 mM BaCl 2 , propagated for 6 days, at which stage they form visible colonies. Following this, encapsulated cells were induced to differentiate to DE and subsequently to PP, following the protocol detailed in Figure 2A [4, 6, 23] . Cell viability was evaluated on days 1, 6, 10, and 14 after encapsulation using the LIVE/DEAD assay. As illustrated in Figure 2B To further characterize the dynamics of cell growth, the images from the LIVE/DEAD assay were quantified using Metamorph image analysis software. The colony area (μm 2 ) of each live colony was measured, and the dynamics of average colony area for each capsule configuration was quantified ( Figure 2C ). In general, for all crosslinking conditions, the cell colony size increased initially with propagation. The extent of the growth was, however, strongly dependent on the capsule property. For example, by day 6, cells encapsulated using 10 mM BaCl 2 had a larger area as compared to the other conditions. Overall, increased BaCl 2 concentration resulted in a progressive decrease in cell colony size. This trend was apparent at the end of propagation stage and continued through the rest of the differentiation stages, with later stages showing an enhanced effect of substrate composition on colony size. An exception to this was the 100 mM BAlg condition, which had minimal growth in cell colonies all through the propagation and differentiation stages. As noted before, the 50 and 100 mM BAlg conditions showed some uninhibited growth, potentially from gel cracking, which are depicted as outliers (circled in black)
in Figure 2C . These results clearly show that growth of encapsulated hPSCs is strongly determined by properties of encapsulating gel, with increased gel stiffness suppressing growth.
Consistent with colony sizes, quantification of cell proliferation by the AlamarBlue assay also showed a strong dependence on substrate stiffness. As shown in Figure 3A , cells encapsulated in softer capsules (10-20 mM BaCl 2 ) are highly proliferative, and resulted in distinct colonies within the capsule. However, stiffer substrates (50, 100 mM BaCl 2 ) were less supportive of proliferation and hence failed to give rise to cell colonies. Along with proliferation, cell death was measured using the LDH assay, to verify if changing capsule properties are having any toxic effect on the cells. As shown in Figure 3B , cell death was most predominant in Day 1, immediately after encapsulation. Beyond that, cell death is somewhat suppressed for most of the conditions, while the cells remain highly proliferative as judged by AlamarBlue assay. It is important to note that cell seeding for all conditions was 1x10 6 cells/ml, and the peak death observed was less than 2.5x10 5 on day 1 for the 10 mM BaCl 2 condition. While this trend is consistent across the softer gels, cells encapsulated in the stiffer gels remain somewhat static.
They are neither proliferative, nor show significant cell death. Overall, the above results clearly
show that BAlg capsules in the range of 10 -20 mM BaCl2 (~4-7 kPa) are supportive of hESC proliferation and colony formation. While the stiffer gels were not necessarily toxic, they did not support sufficient colony growth to be a feasible option for encapsulation. Having confirmed germ layer commitment, the next step was analysis of the effect of substrate stiffness on pancreatic commitment. We first looked at HNF4α, which is a marker of the primitive gut tube, and is expressed in pancreatic development between the DE and PP stages.
Interestingly, consistent with the DE makers, gene expression of HNF4α increased as BAlg capsule stiffness increased ( Figure 5A ), but lacked the biphasic nature and was highest under the stiffest condition tested: ~510-fold increase over UD hESCs at 100 mM BaCl 2 . Figure 5B shows gene expression of PTF1A, a precursor to PDX1, which showed a similar increasing trend with BAlg capsule stiffness, from ~3-fold to ~3300-fold upregulation over UD hESCs. A crucial transcription factor for endocrine pancreatic development is PDX1, which is also necessary for β cell maturation. In contrast with the previous analysis, PDX1 gene expression showed strong inverse relationship with BAlg capsule stiffness ( Figure 5C ). The highest PDX1
expression was obtained at 10 mM BaCl 2 which resulted in ~3800-fold increase over UD hESCs. All of the other gel conditions tested had a significantly lower PDX1 gene expression (~370 -580 fold increase over UD hESCs).
We subsequently compared the morphology of PP colonies across the gel conditions. At the end of PP induction, the BAlg capsules were dissolved and the collected cell colonies were sectioned and stained with H&E to visualize the colony morphology for each BAlg condition ( Figure 5D ). Cells differentiated in the 10 and 15 mM BAlg capsules resulted in colonies which were visibly less dense in higher BaCl 2 concentrations. The cell colonies within 10 and 15 mM
BAlg were found to have distinct cavities (indicated with black arrows) within the colonies, which was significantly reduced at 20 mM condition and completely absent in 50 and 100 mM BAlg capsules. As indicated earlier, 50 and 100 mM BAlg capsules resulted in either small restricted colonies or in some cases, large elongated colonies.
Pancreatic differentiation was next confirmed by immunostaining of colony sections for PDX1.
Consistent with the gene expression analysis, cells encapsulated in the 10 mM BaCl 2 gel were strongly positive for the protein PDX1 ( Figure 5E ). While PDX1 protein expression was also detected in 15 mM and 20 mM conditions, the number of PDX1 positive cells decreased significantly with increasing gel stiffness. In the stiffest gels formed with 50 or 100 mM BaCl 2 , no detectable cells were positive for the protein PDX1. Hence, while higher stiffness was conducive for mesendoderm and DE differentiation, the lower stiffness BAlg capsule was more supportive of endocrine pancreatic differentiation, as shown by high PDX1 gene and protein expression.
Since ECM can play a significant role in modulating cell fate, we further analyzed the PP colonies across gel conditions for relevant ECM proteins. In particular, laminin and collagen 1 are known to be important basement membrane and structural proteins in the pancreas, respectively [52] [53] [54] and were analyzed by immunostaining. Consistent with the differentiation data, the presence of ECM was more evident in lower stiffness gels ( Figure 5F ). Interestingly, the ECM deposition appeared to be localized primarily around the cavities within the colony (indicated with white arrows).
Capsule Properties impact signaling at both the DE and PP stage
Our results showed that in spite of identical chemical induction, the differentiation potential of the encapsulated cells was significantly modified by the properties of the encapsulating substrate. Further, the effect of the substrate was specific to the stage of differentiation and not consistent throughout. Since signaling pathways are also known to have similar stage specific effect on differentiation, we hypothesized that substrate properties are modulating the efficacy of relevant signaling molecules. The TGFβ pathway is known to play a critical role in the process of endoderm and pancreatic differentiation. High activation is necessary for endoderm induction, while it is detrimental to pancreatic differentiation. Hence to analyze how substrate properties are affecting differentiation, we chose to measure the SMAD molecules, which are key effectors of the TGFβ pathway. However, the complex interactions between parallel pathways make it difficult to understand pathway behavior by analyzing molecules and pathways in isolation [55] .
Hence we also measured pERK and pAKT which are known to have significant interaction with the TGFβ pathway. Using a Luminex-based MagPix assay, we measured the expression of relevant signaling molecules after the DE and PP stage in 10 and 20 mM BaCl 2 condition (Figures 6, 7) . These conditions were chosen because they had the most contrasting effect between the DE and PP stage differentiation. We first focused on how gel stiffness influenced signaling at the DE stage ( Figure 6A ). Total TGFβRII levels were significantly lower in the 20 mM BAlg, while t-SMAD4 levels were insensitive to changes in response to capsule stiffness.
Interestingly, the primary effectors of the TGFβ pathway, pSMAD2/3, showed an opposite trend.
While pSMAD2 was significantly lower in the 20 mM BAlg compared to 10 mM BAlg, pSMAD3
was significantly higher. The cross talk molecule pERK1/2 also showed significantly higher expression in the 20 mM BAlg, while pAKT, a negative regulator of the TGFβ pathway, showed significantly lower expression in this condition compared to 10 mM BAlg. To evaluate the level of negative regulation, we analyzed the ratio of pSMAD2/3/pAKT to estimate the level of available pSMAD2/3 which can influence differentiation ( Figure 6B ). While the ratio of pSMAD2/pAKT was not significantly different between the gel conditions, pSMAD3/pAKT was significantly higher in 20 mM BAlg. Both higher levels of pSMAD3 and higher pSMAD3/pAKT ratio in 20 mM BAlg condition, as compared to the 10 mM BAlg condition, indicates a larger pool of active pSMAD3 molecules are available to direct mesendoderm gene transcription.
High TGFβ signaling activation is of paramount importance for DE induction; however, following DE specification, activation of this pathway is detrimental to pancreatic commitment [56] . In our experimental set-up, beyond the DE stage there was no exogenous activation of the TGFβ pathway. Even then we observed significant dynamics of the pathway molecules, the nature of which depended on the substrate properties ( Figure 7A ). Both 10 and 20 mM BAlg conditions showed a significant increase in the receptor level and t-SMAD4 levels from DE to PP. However for 20 mM BAlg, the key signaling molecules pSMAD2/3 remained similar between DE and PP. BAlg at the PP stage. However, as mentioned earlier, it is difficult to conclude on the state of signaling by evaluating signaling pathways in isolation. Hence we also evaluated pAKT and pERK levels to characterize the signaling events in more detail ( Figure 7A ). We observed that both pERK and pAKT increased significantly from the DE to PP stage under both gel conditions. However, the difference was insignificant for both signaling molecules between the two conditions at the PP stage. These pathways alone do not explain the observed difference in differentiation. Hence we analyzed the ratio between the key signaling molecules, in order to quantify the interaction. We observed that the pSMAD2/3/pAKT ratio was significantly suppressed when the cells were differentiated from DE to PP, in both the gel conditions with the exception of pSMAD2/pAKT for 20 mM BAlg ( Figure 7B ). This indicates that the availability of active pSMAD levels lower upon withdrawal of ActivinA, while moving from DE to PP. While this analysis explains the feasibility of PP differentiation, it does not explain the superior performance of the 10mM BAlg condition.
We next specifically analyzed pathways which are being directly modulated for pancreatic induction. This includes inhibition of the sonic hedgehog (SHH) signaling pathway, the presence of which promotes liver bud formation [56] . Hence, we examined the substrate-specific effect of SHH inhibition by measuring the gene expression levels of the SHH ligand and GLI1, a 
Discussion
The objective of this study was to evaluate the feasibility of using BAlg encapsulation for pancreatic differentiation of hESCs, and how capsule properties regulate growth and differentiation. These capsules can then be subsequently used for implantation for T1D Low stiffness capsules were supportive of both cell growth, and pancreatic differentiation.
Signaling pathways analysis showed that increasing capsule stiffness activated TGFβ signaling, which supports DE differentiation, and SHH signaling, suppressing PP differentiation. Hence in the current study we report for the first time, specific barium alginate configurations most supportive of growth and pancreatic differentiation of encapsulated hPSCs.
In evaluating the growth and differentiation properties of barium alginate capsules, the parameter we modulated was the crosslinking concentration. Even though the encapsulated cells were continuously induced by specific growth factors and chemical inducers, we hypothesized that the substrate properties play a critical role in modulating cell fate, as has been well known in stem cell literature, [40, 42, 59] . In islet encapsulation studies, 20 mM BaCl 2 capsules are the most ubiquitous, which results in a stiffness of 6.8 kPa. This is in a similar range as has been reported in mouse, 1.210±0.77 [43] , and adult human pancreata, 1.4±2.1 kPa -4.4 ±5.1 kPa [60] . Based on this, we selected a wide range of cation concentrations encompassing this range, where capsules made using 10 -20 mM BaCl 2 (~4 -7 kPa) most closely mimicked the stiffness of the pancreas in vivo. As seen in previous reports, increasing BaCl 2 concentration increases the young's modulus, E (kPa), of the resulting alginate capsule [28, 48] , which significantly affected both growth and differentiation of the encapsulated hESCs.
Most significantly, BAlg capsules using 10-20 mM BaCl 2 (first regime) was very supportive of cell proliferation, resulting in large viable cell colonies by the end of the 14 day differentiation protocol. In contrast 50 -100 mM BaCl 2 (second regime) resulted in marginal proliferation into small colonies. Although gel stiffness increased as BaCl 2 concentration increased in the first regime, it was not adverse to cell growth and differentiation. While in the second regime, the resulting stress from the capsule stiffness was too high to sustain healthy cell growth. It was not entirely clear if this poor viability was due to potential effects of barium toxicity [61] , or from the high physical stress imparted by the capsule stiffness preventing cell proliferation. However, 1 day after hESC encapsulation, the highest cell death by the LDH assay was found in the lower barium concentration, which still showed 97% viability. Additionally, the high stiffness capsules were found to be cracking on the capsule surface and likely within the capsules, resulting in distinctly large and irregularly shaped cell colonies. This leads us to believe that the capsule was physically restraining the cells, and relieving the stress resulted in rapid cell growth in the cracked regions. The possibility of healthy cell growth in high barium capsule indicates the effects of barium toxicity in this system are minimal. This is further supported by the observation that better viability was observed in 100 mM BAlg, compared to the 50 mM BAlg on day 14 in Figure 2B . Barium concentration was higher in 100 mM BAlg, but cracking of the gel resulted in cell overgrowth, and more viable cells than in 50 mM BAlg, containing less barium. However, barium may still be toxic to the body in future implantation studies. Matching the most supportive capsule stiffness found in this study using a combination of calcium and low barium concentration, as done previously for islet encapsulation [62] , may be useful in mitigating potential barium toxicity in the body. Taken together, this indicates that within the stiffness range of approximately 4 -7 kPa, it is possible to maintain healthy growth and high expansion of hESCs, while beyond this range is not amenable to cell growth.
While the effect of stiffness was clear on cell viability and expansion, the effect of stiffness on pancreatic differentiation was much more complex. We evaluated the most supportive capsule
properties to obtain PP cells, since implantation of PP cells have been widely reported to be successful in reinstating glucose homeostasis in diabetic mice upon implantation [63] [64] [65] [66] . While the higher stiffness capsules are much stiffer than most soft tissue, it was not obvious how stiffness would influence differentiation in the presence of chemical differentiation factors. 2D hyaluronic acid gels of stiffness 2.1 kPA compared to controls [68] . While this study only investigated a narrow stiffness range with only three gel stiffness's (1.3, 2.1, and 3.5 kPa) in 2D, it confirms that a delicate balance must be struck between physical and chemical cues. pathway. This trend follows previous reports for prostatic epithelial cells and human embryonic kidney cells, which have shown that pAKT suppresses TGFβ signaling specifically through suppression of SMAD3 phosphorylation, and not SMAD2 [72, 73] . Additionally, we also examined pERK1/2 expression, a primary effector of the MAPK pathway. We observed significantly higher pERK1/2 expression in the 20 mM BAlg conditions. DE stage differentiation is induced by activation of the WNT pathway with Wnt3A, in addition to the TGFβ pathways. signaling activation independent of the "classical" ligand-smoothened HH activation [78] . As we have seen in our differentiation studies; this results in the ineffectiveness of HH signaling inhibitors like CYC. It is possible that the increase in substrate stiffness is activating "nonclassical" SHH signaling, independent of the ligand-receptor binding.
Conclusions
In the present study we evaluated the feasibility of adopting BAlg capsules as a unifying platform for hPSC growth, differentiation and implantation. Since BAlg is well studied for islet transplantation, we focused our study on its usefulness for hPSC encapsulation and pancreatic differentiation. Our results clearly indicate the excellent performance of BAlg capsules in supporting growth and pancreatic differentiation of encapsulated hPSCs, highlighting its potential as a single platform for hPSC scale-up, differentiation and final implantation. However, it also highlights the importance of considering capsule synthesis as an important parameter.
Cell growth and differentiation were strongly dependent on the stiffness of the substrate. We determined that capsule stiffness of approximately 4 to 7 kPa was most supportive of cell proliferation, while ~3.9 was best for pancreatic differentiation. Analysis of the signaling pathway indicated increased stiffness strengthens TGFβ signaling, driving DE differentiation. However, it also strengthens SHH signaling, which is detrimental to PP differentiation. Future implantation studies will first require investigation of the perm-selectivity of the barium alginate capsules with changing stiffness to determine the exact capsule parameters which support viability, differentiation, and immunoisolation from the patient immune system. The results were considered significant if * P<0.05.
